CSL Behring
Search results
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
CSL Limited was incorporated in 1991 and listed on the Australian Securities Exchange (ASX) in 1994. Today, CSL comprises businesses with longstanding, specialized expertise: CSL Behring, a global leader in rare and serious diseases; its subsidiary CSL Plasma, which operates one of the world’s largest plasma collection networks;
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions.
CSL's 2024 Full Year Financial Results. We will announce our 2024 Full Year Financial Results on Tuesday, 13 th August 2024 (AEST). Our 2024 Full Year Financial Results Webcast will be live from 11am on announcement day. Pre-register for the Webcast here.
Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
CSL Seqirus, a Proud Champion of Pandemic Preparedness, Signs an Agreement with the European Commission to Provide Pre-Pandemic Vaccines to the EU. Jun 11, 2024 - CSL Seqirus to provide 665,000 pre-pandemic (zoonotic) vaccines to support fifteen EU and EEA Member States.
Get the latest CSL Ltd (CSL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Jun 11, 2024 · CSL Seqirus to provide 665,000 pre-pandemic (zoonotic) vaccines to support fifteen EU and EEA Member States. Outbreaks of highly pathogenic avian influenza (HPAI) viruses in birds and poultry have... May 30, 2024
CSL's latest and archived Annual Reports. CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.
The 2021 Annual General Meeting (AGM) of CSL Limited (ABN 99 051 588 348) will be held online on Tuesday, 12 October 2021 at 10am (Melbourne time). Contents 1 Chair and CEO message 2 2 2021 Performance 6 Business performance highlights 6 Financial highlights 7 3 Our Company 8 CSL at a glance 8 Our businesses 8 COVID-19: Our efforts 9
